On a specific written request by the Secretary, the manufacturer, packer, or distributor of any prescription drug that is sold or distributed in this State shall give the Secretary:
(1) Any information that the manufacturer, packer, or distributor has about the biological availability and clinical performance of the drug; and
(2) Any comparative information that the manufacturer, packer, or distributor has about any drug, of the same established name, that is manufactured, packed, or distributed by another person.
Structure Maryland Statutes
Title 21 - Food, Drugs, and Cosmetics
Subtitle 2 - Maryland Food, Drug, and Cosmetic Act
Section 21-216 - Adulterated Drugs and Devices
Section 21-217 - Misbranded Drugs and Devices -- in General
Section 21-218 - Additional Grounds of Drug Misbranding
Section 21-220 - Prescription Requirements
Section 21-222 - Construction of 21-220 and 21-221
Section 21-223 - New Drugs -- in General
Section 21-224 - New Drugs -- Exemption When Intended for Investigational Use Only
Section 21-225 - New Drugs -- Inspection of Records
Section 21-226 - Printed Information for Use of Practitioners
Section 21-227 - Provision of Information on Request of Secretary